2m 2m 2m 2m 2m 2m 2m
MIMEDX GROUP (MDXG)
NASDAQ
$3.68+$0.10 (+2.94%)
Price as of Jun 03, 2026 6:02 PM EDT- $548.1MMarket Cap
- -44.91%1-Year Change
- BiotechnologyIndustry
MIMEDX GROUP (MDXG)
$3.68+$0.10 (+2.94%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 418.6M +19.99% | 348.9M +8.52% | 321.5M +20.03% | 267.8M +3.57% | |
Cost of Revenue | 73.0M +21.54% | 60.1M +9.96% | 54.6M +13.08% | 48.3M +11.63% | |
Gross Profit | 345.6M +19.67% | 288.8M +8.23% | 266.8M +21.55% | 219.5M +1.95% | |
Sales and Marketing Expense | 266.2M +18.26% | 225.1M +6.61% | 211.1M +1.12% | 208.8M +5.26% | |
Research and Development Expense | -15.1M +22.33% | -12.3M -2.56% | -12.7M -44.52% | -22.8M +31.62% | |
Depreciation and Amortization Expense | 14.9M +552.96% | 2.3M +199.08% | 762,000 +8.70% | 701,000 -14.51% | |
Total Operating Expenses | 73.0M +21.54% | 60.1M +9.96% | 54.6M +13.08% | 48.3M +11.63% | |
Operating Profit | 63.9M +8.53% | 58.9M +58.60% | 37.1M +248.64% | -25.0M +395.95% | |
Interest Income | 4.7M +60.85% | 2.9M N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.6M +59.05% | -1.0M -84.42% | -6.5M +28.73% | -5.0M +0.72% | |
Interest Income and Expense and Net | 3.1M +61.79% | 1.9M +129.83% | -6.5M +28.73% | -5.0M +0.72% | |
Total Nonoperating Income and Expense | -558,000 -1.24% | -565,000 +2,073.08% | -26,000 +550.00% | -4,000 -82.61% | |
Income before Taxes | 66.3M +15.65% | 57.3M +87.03% | 30.6M +202.14% | -30.0M +198.77% | |
Income Taxes | 17.7M +15.61% | 15.3M +141.56% | -36.8M -17,966.99% | 206,000 -16.60% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 48.6M +14.52% | 42.4M -27.15% | 58.2M +292.83% | -30.2M +193.60% | |
Net Income from Continuing Operations Applicable to Common | 48.6M +15.67% | 42.0M -37.72% | 67.4M +283.37% | -36.8M +123.96% | |
Basic EPS and Net Income | 0.33 +13.79% | 0.29 -27.50% | 0.40 +221.21% | -0.33 +120.00% | |
Diluted EPS and Net Income | 0.32 +14.29% | 0.28 -24.32% | 0.37 +212.12% | -0.33 +120.00% | |
Basic Weighted Average Shares | 147.8M +0.55% | 147.0M +26.17% | 116.5M +3.18% | 112.9M +2.32% | |
Diluted Weighted Average Shares | 149.7M +0.45% | 149.0M +2.11% | 146.0M +29.27% | 112.9M +2.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 166.1M +59.10% | 104.4M +27.34% | 82.0M +24.34% | 66.0M -24.27% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 166.1M +59.10% | 104.4M +27.34% | 82.0M +24.34% | 66.0M -24.27% | |
Total Current Assets | 277.5M +44.60% | 191.9M +16.82% | 164.3M +22.40% | 134.2M -9.64% | |
Accumulated Depreciation | 23.5M +10.21% | 21.3M +6.46% | 20.0M -44.25% | 35.9M +9.27% | |
Property and Plant and Equipment and Net | 4.7M -20.71% | 5.9M -14.77% | 7.0M -11.23% | 7.9M -14.28% | |
Total Long-Term Assets | 7.3M +557.69% | 1.1M +439.51% | 205,000 +38.51% | 148,000 -20.43% | |
Total Assets | 342.7M +29.83% | 263.9M +10.40% | 239.0M +39.44% | 171.4M -8.78% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.5M +50.00% | 1.0M 0.00% | 1.0M N/A | N/A N/A | |
Total Current Liabilities | 64.3M +40.95% | 45.6M -0.90% | 46.0M +5.63% | 43.6M +2.83% | |
Total Long-Term Debt | 16.5M -7.64% | 17.8M -62.93% | 48.1M -1.02% | 48.6M +0.97% | |
Total Long-Term Liabilities | 5.4M -27.24% | 7.4M +232.12% | 2.2M -53.43% | 4.8M -1.97% | |
Total Liabilities | 86.1M +21.60% | 70.8M -26.49% | 96.3M -0.61% | 96.9M +1.65% | |
Retained Earnings | -42.7M -53.23% | -91.3M -31.73% | -133.7M -30.34% | -191.9M +18.67% | |
Total Stockholders Equity | 256.5M +32.85% | 193.1M +35.31% | 142.7M +893.40% | -18.0M -22,036.59% | |
Total Shares Outstanding | 148.1M +0.79% | 146.9M +0.48% | 146.2M +28.60% | 113.7M +1.59% | |
Cash Flow | |||||
Cash from Operating Activities | 74.0M +11.79% | 66.2M +147.24% | 26.8M +249.64% | -17.9M +802.77% | |
Capital Expenditures | 1.0M -38.62% | 1.7M -15.30% | 2.0M +31.24% | 1.5M -52.95% | |
Cash from Investing Activities | -6.9M -28.14% | -9.6M +344.69% | -2.2M -18.98% | -2.7M -21.65% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -5.4M -84.17% | -34.2M +299.05% | -8.6M +1,377.59% | -580,000 -82.70% | |
Financials Ratio | |||||
Gross Margin | 82.56% -0.27% | 82.78% -0.27% | 83.01% +1.27% | 81.96% -1.56% | |
Operating Margin | 15.26% -9.55% | 16.87% +46.14% | 11.55% +223.84% | -9.32% +378.87% | |
Return on Assets | 16.02% -5.04% | 16.87% -40.55% | 28.37% +268.81% | -16.81% +218.60% | |
Return on Equity | 21.61% -14.47% | 25.26% -72.94% | 93.37% -72.32% | 337.28% -98.89% | |
Revenue Growth | 19.99% +134.55% | 8.52% -57.43% | 20.03% +461.33% | 3.57% -14.69% | |
Current Ratio | 4.32 +2.59% | 4.21 +17.88% | 3.57 +15.88% | 3.08 -12.13% | |
Cash Ratio | 2.58 +12.87% | 2.29 +28.49% | 1.78 +17.71% | 1.51 -26.35% | |
Debt-to-Equity Ratio | 0.07 -28.21% | 0.10 -71.66% | 0.34 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.05 -26.51% | 0.07 -65.29% | 0.21 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow